Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.
about
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerClinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX.CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registryOutcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsRelative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.Pathological characteristics of BRCA-associated breast cancers in Hispanics.Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations.High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.BRCA1/2 mutations and triple negative breast cancers.
P2860
Q33419708-AF344D84-F875-4C91-8F30-02AC0F5ECB7AQ33654767-027989AD-04F0-4F96-A461-C9F3BB91B799Q33739351-BDB691B0-148E-4746-BB1E-A34FB3289C66Q34625335-9A1989F7-9FB5-4FBB-8B66-F7A70B35284BQ34991306-8C18B628-7E3F-4FDB-863E-8A4264F98D2EQ35050626-D460B4E6-52A8-4A5A-9CE7-D90F650D9ADBQ35100315-E39A450C-F5AB-477A-A1CD-F1E4D910DAA2Q36119158-5A227ADF-E374-4EBB-89AA-F71F986A1A76Q36478218-F520916F-89DA-4222-A581-411895F0099DQ36643738-C75B2C52-752A-48C8-B459-EFC46E8DA07BQ36793398-6C26825E-0C67-49C1-9666-05B50A549DA8Q37407985-7E972A6D-956E-429F-92D6-443F66F01763
P2860
Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Pathological features and BRCA ...... pausal breast cancer patients.
@en
type
label
Pathological features and BRCA ...... pausal breast cancer patients.
@en
prefLabel
Pathological features and BRCA ...... pausal breast cancer patients.
@en
P2093
P1476
Pathological features and BRCA ...... opausal breast cancer patients
@en
P2093
P304
P407
P577
2001-06-01T00:00:00Z